Skip to main content

Table 2 PD-L1 positive rate in early-stage lung adenocarcinoma from AIS, MIA to IAC stage IA1–IA3

From: Expression of PD-L1 through evolution phase from pre-invasive to invasive lung adenocarcinoma

 

PDL1 (−) (%)

PD-L1≥1%

p value

PD-L1≥50%

p value

Total

AIS

11

100.00

0

0.00

< 0.001

0

0.00

0.012

11

MIA

198

99.00

2

1.00

 

0

0.00

 

200

IA1

244

92.78

19

7.22

 

1

0.38

 

263

IA2

432

88.71

55

11.29

 

8

1.64

 

487

IA3

139

85.80

23

14.20

 

6

3.70

 

162

IA (Grade 1)

20

86.96

3

13.04

< 0.001

0

0.00

< 0.001

23

IA (Grade 2)

739

91.23

71

8.77

 

9

1.11

 

810

IA (Grade 3)

56

70.89

23

29.11

 

6

7.59

 

79

Lepidic dominant

83

92.22

7

7.78

< 0.001

0

0.00

< 0.001

90

Acinar dominant

660

90.91

66

9.09

 

7

0.96

 

726

Papillary dominant

36

92.31

3

7.69

 

0

0.00

 

39

Micropapillary dominant

3

60.00

2

40.00

 

0

0.00

 

5

Solid dominant

10

45.45

12

54.55

 

5

22.73

 

22

Invasive mucinous

25

89.29

3

10.71

 

1

3.57

 

28

STAS(+)

37

75.51

12

24.49

< 0.001

3

6.12

0.017

49

STAS(-)

987

91.90

87

8.10

 

12

1.12

 

1074

Vascular invasion (+)

12

66.67

6

33.33

< 0.001

3

16.67

0.001

18

Vascular invasion (-)

1012

91.58

93

8.42

 

12

1.09

 

1105

Lymphatic invasion (+)

1

100.00

0

0.00

N/A

0

0.00

N/A

1

Lymphatic invasion (-)

1023

91.10

99

9.68

 

15

1.46

 

1122

  1. AIS Adenocarcinoma in situ; MIA Minimally invasive adenocarcinoma; IAC Invasive adenocarcinoma; STAS Spread through air space, N/A Not applicable